An inexpensive drug that’s been used for decades in transplant surgeries can delay the progression of type 1 diabetes in those newly diagnosed, new research suggests.
In previous studies, a high dose of the immune-suppressing drug polyclonal…
Continue Reading
News Source: www.livescience.com

Leave a Reply